| Anlotinib Hydrochloride Capsules Combined With TQB2450 Injection in Esophageal Squamous Cell Carcinoma Patients (NCT05252078) | Jiangxi Provincial Cancer Hospital | 2022-06-02 |
| Clinical Trial to Evaluate the Safety and Efficacy of IM96 CAR-T Cells Therapy in Patients With Advanced Digestive System Neoplasms (NCT05287165) | Beijing Immunochina Medical Science & Technology Co., Ltd. | 2022-03-10 |
| Hepatic Artery Infusion Chemotherapy Plus Donafenib in Patients With Hepatocellular Carcinoma After Surgery (NCT04962958) | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | 2021-12-27 |
| Spanish Series of Patients Treated With the Radionuclide Lutetium177 (NCT04949282) | Sociedad Española de Medicina Nuclear e Imagen Molecular | 2021-05-10 |
| Palliative Primary Tumor Resection in Minimally Symptomatic Patients With Colorectal Cancer and Synchronous Unresectable Metastases (NCT05322486) | State Scientific Centre of Coloproctology, Russian Federation | 2020-10-29 |
| Effectiveness of an Educational Intervention Aimed at Increasing the Emotional Competencies of Patients Under Surveillance After Antineoplastic Treatment of Oesogastric or Bronchopulmonary Cancer (NCT04556344) | University Hospital, Lille | 2020-10-26 |
| Efficacy and Safety of SOX Regimen Combined With Camrelizumab as Neoadjuvant Treatment in Locally Advanced Gastric Cancer: a Phase II, Single-arm Study (NCT05602935) | The Second Affiliated Hospital of Fujian Medical University | 2020-09-16 |
| TACE, Sorafenib and PD-1 Monoclonal Antibody in the Treatment of HCC (NCT04518852) | Sichuan Cancer Hospital and Research Institute | 2020-09-14 |
| Anlotinib Hydrochloride Capsules Combined With CAPEOX in RAS and BRAF Wild-type mCRC Patients (NCT04080843) | Zhejiang University | 2019-11-15 |
| A Study of LP002 for the Treatment of Patients With Malignant Digestive System Neoplasms (NCT04755543) | Taizhou HoudeAoke Biomedical Co., Ltd. | 2019-06-17 |
| The Maintenance Treatment of Apatinib/Capecitabine Versus Observation in Advanced Gastric Cancer (NCT03889626) | Fudan University | 2019-03-22 |
| Evaluation of Ocoxin-Viusid® in Advanced Pancreatic Adenocarcinoma (NCT03717298) | Catalysis SL | 2018-10-30 |
| Apatinib Versus Bevacizumab in Second-line Therapy for Colorectal Cancer(ABST-C) (NCT03271255) | Shenzhen People's Hospital | 2018-05-23 |
| Observatory of the Quality of Surgical Procedures for Digestive Cancers (NCT03681600) | Moroccan Society of Surgery | 2018-01-01 |
| Educational Intervention to Increase the Emotional Competence of Patients With Oesogastric and Bronchopulmonary Cancers (NCT03306693) | University Hospital, Lille | 2017-10-26 |
| Gradual Versus Immediate Goal-dose Enteral Nutrition in Abdominal Surgery Patients (NCT03117348) | Jinling Hospital, China | 2017-04-15 |
| Early Versus Delayed Parenteral Nutrition in Abdominal Surgical Patients (NCT03115957) | Jinling Hospital, China | 2017-04-14 |
| BowelScope: Accuracy of Detection Using ENdocuff Optimisation of Mucosal Abnormalities (NCT03072472) | South Tyneside and Sunderland NHS Foundation Trust | 2017-02-14 |
| Continuation Study of Entinostat in Combination With Pembrolizumab in Patients With Advanced Solid Tumors (NCT02909452) | Syndax Pharmaceuticals | 2016-09-20 |
| Cardiac Safety Study of Entinostat in Men and Women With Advanced Solid Tumors (NCT02897778) | Syndax Pharmaceuticals | 2016-08-24 |
| EUS-guided RFA for Solid Abdominal Neoplasms (NCT03221335) | Chinese University of Hong Kong | 2016-05-01 |
| Autologous Tumor Tissue Antigen-sensitized DC-CIK Cells Combined With Chemotherapy for Esophageal Cancer (NCT02644863) | Shenzhen Hornetcorn Bio-technology Company, LTD | 2015-12-01 |
| DC-CIK Combined With TACE in the Treatment of Hepatocellular Carcinoma (NCT02487017) | Shenzhen Hornetcorn Bio-technology Company, LTD | 2015-05-01 |
| Surefire Infusion System vs. Standard Microcatheter Use During Holmium-166 Radioembolization (NCT02208804) | UMC Utrecht | 2014-11-01 |
| Study of Autologous Tumor Lysate-pulsed D-CIK Combined With Chemotherapy for Gastric Cancer (NCT02215837) | Shenzhen Hornetcorn Bio-technology Company, LTD | 2014-08-01 |
| Adoptive Cell Therapy Plus Chemotherapy and Radiation After Surgery in Treating Patients With Colorectal Cancer (NCT02202928) | Shenzhen Hornetcorn Bio-technology Company, LTD | 2014-07-01 |
| Evaluation of Predictive Visual Analog Scale (VAS) for Determining the Ingesta of Patients Carrying a Digestive Cancer (NCT02781532) | Centre Hospitalier Universitaire de Nice | 2014-04-01 |
| Nab-paclitaxel and Gemcitabine vs Gemcitabine Alone as Adjuvant Therapy for Patients With Resected Pancreatic Cancer (the "Apact" Study) (NCT01964430) | Celgene | 2014-03-28 |
| Celiac Plexus Radiosurgery for Pain Management (NCT02356406) | Sheba Medical Center | 2014-01-01 |
| A Phase III Study of 2nd-line XELIRI ± Bevacizumab vs. FOLFIRI ± Bevacizumab in mCRC (NCT01996306) | Epidemiological and Clinical Research Information Network | 2013-12-02 |
| Molecular, Pathologic and MRI Investigation of the Prognostic and Redictive Importance of Extramural Venous Invasion in Rectal Cancer (MARVEL) Trial (NCT01995942) | Royal Marsden NHS Foundation Trust | 2013-06-07 |
| Clinical Trial: Effectiveness and Efficiency of Physical Exercise in Cancer Patients (NCT01786122) | Basque Health Service | 2013-04-01 |
| 89Zr-MMOT PET Imaging in Pancreatic and Ovarian Cancer Patients (NCT01832116) | University Medical Center Groningen | 2013-03-01 |
| A Study of 2nd-line FOLFIRI ± Bevacizumab vs. Irinotecan ± Bevacizumab in mCRC (NCT03303495) | Sun Yat-sen University | 2011-11-14 |
| Efficacy and Tolerability of ABT-869 Versus Sorafenib in Advanced Hepatocellular Carcinoma (HCC) (NCT01009593) | Abbott | 2010-01-01 |
| Optimum Timing for Surgery After Pre-operative Radiotherapy 6 vs 12 Weeks (NCT01037049) | Royal Marsden NHS Foundation Trust | 2009-10-16 |
| Low Rectal Cancer Study (MERCURY II) (NCT02005965) | Royal Marsden NHS Foundation Trust | 2007-08-13 |
| Laser Interstitial Thermal Therapy Under "Real Time" MRI Guidance for "Minimal Invasive" Treatment of Liver Metastasis (NCT00392366) | BioTex, Inc. | 2006-07-01 |